Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
Hideto Kawaratani(Nara Medical University), Hitoshi Yoshiji(Nara Medical University), Takuji Torimura(Omuta hospital), Shuji Terai(Niigata University Medical and Dental Hospital), Yoshihito Uchida(Saitama Medical University), Tsunekazu Oikawa(University of North Carolina at Chapel Hill), Ryoji Tatsumi(Sapporo Kosei General Hospital), Naoto Kawabe(Fujita Health University), Akira Sakamaki(Niigata University), Kazuo Okumoto(Yamagata University), Kazuhiko Koike(Kanto Central Hospital), Satoshi Mochida(Saitama Medical University), Yoji Ishizu(Nagoya University), Tomokazu Matsuura(Jikei University School of Medicine), Masatoshi Ishigami(Nagoya University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Shuhei Hige(Yamagata University), Taro Takami(Yamaguchi University), Kei Endo(Iwate Medical University), Takumi Kawaguchi(Kurume University), Yasuteru Kondo(Sendai Kousei Hospital), Yasuhiro Takikawa(Iwate Medical University), Norikazu Tanabe(Yamaguchi University)
Cited by 16
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536